Literature DB >> 15458962

Large scale evidence and replication: insights from rheumatology and beyond.

J P A Ioannidis1.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15458962      PMCID: PMC1755405          DOI: 10.1136/ard.2004.027979

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  19 in total

1.  Secular changes in the quality of published randomized clinical trials in rheumatology.

Authors:  Catherine L Hill; Michael P LaValley; David T Felson
Journal:  Arthritis Rheum       Date:  2002-03

Review 2.  Pharmaceutical industry sponsorship and research outcome and quality: systematic review.

Authors:  Joel Lexchin; Lisa A Bero; Benjamin Djulbegovic; Otavio Clark
Journal:  BMJ       Date:  2003-05-31

Review 3.  Genetic associations: false or true?

Authors:  John P A Ioannidis
Journal:  Trends Mol Med       Date:  2003-04       Impact factor: 11.951

4.  Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease.

Authors:  Kirk E Lohmueller; Celeste L Pearce; Malcolm Pike; Eric S Lander; Joel N Hirschhorn
Journal:  Nat Genet       Date:  2003-01-13       Impact factor: 38.330

Review 5.  Reporting of outcomes in arthritis trials measured on ordinal and interval scales is inadequate in relation to meta-analysis.

Authors:  P C Gøtzsche
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

6.  Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Jean-Charles Piette; Josep Font; Munther A Khamashta; Yehuda Shoenfeld; María Teresa Camps; Soren Jacobsen; Gabriella Lakos; Angela Tincani; Irene Kontopoulou-Griva; Mauro Galeazzi; Pier Luigi Meroni; Ronald H W M Derksen; Philip G de Groot; Erika Gromnica-Ihle; Marta Baleva; Marta Mosca; Stefano Bombardieri; Frédéric Houssiau; Jean-Christophe Gris; Isabelle Quéré; Eric Hachulla; Carlos Vasconcelos; Beate Roch; Antonio Fernández-Nebro; Marie-Claire Boffa; Graham R V Hughes; Miguel Ingelmo
Journal:  Arthritis Rheum       Date:  2002-04

7.  Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome.

Authors:  John P A Ioannidis; Vassilios A Vassiliou; Haralampos M Moutsopoulos
Journal:  Arthritis Rheum       Date:  2002-03

8.  Design and quality considerations for randomized controlled trials in systemic sclerosis.

Authors:  Maria Kyriakidi; John P A Ioannidis
Journal:  Arthritis Rheum       Date:  2002-02

9.  Design, quality, and bias in randomized controlled trials of systemic lupus erythematosus.

Authors:  Fotini B Karassa; Athina Tatsioni; John P A Ioannidis
Journal:  J Rheumatol       Date:  2003-05       Impact factor: 4.666

10.  Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology.

Authors:  F Wolfe; M Lassere; D van der Heijde; G Stucki; M Suarez-Almazor; T Pincus; K Eberhardt; T K Kvien; D Symmons; A Silman; P van Riel; P Tugwell; M Boers
Journal:  J Rheumatol       Date:  1999-02       Impact factor: 4.666

View more
  1 in total

1.  Transdiagnostic Risk Calculator for the Automatic Detection of Individuals at Risk and the Prediction of Psychosis: Second Replication in an Independent National Health Service Trust.

Authors:  Paolo Fusar-Poli; Nomi Werbeloff; Grazia Rutigliano; Dominic Oliver; Cathy Davies; Daniel Stahl; Philip McGuire; David Osborn
Journal:  Schizophr Bull       Date:  2019-04-25       Impact factor: 9.306

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.